BioLight Life Sciences Ltd. (TLV:BOLT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
247.40
-19.80 (-7.41%)
Apr 24, 2026, 1:44 PM IDT
Market Cap22.38M +0.1%
Revenue (ttm)n/a
Net Income-11.73M
EPS-1.98
Shares Out9.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume37,322
Average Volume43,947
Open262.00
Previous Close267.20
Day's Range240.70 - 262.00
52-Week Range209.20 - 661.90
Beta0.37
RSI41.90
Earnings DateApr 6, 2026

About BioLight Life Sciences

BioLight Life Sciences Ltd. engages in the investment, development, management, and commercialization of products in the fields of advanced medical devices, pharmaceuticals, diagnostics, and digital medicine in Israel. The company offers TeaRx, a diagnostic platform intended for point-of-care testing of ophthalmic pathologies through multi-parameter composition analysis of the tear fluid; TeaRx Dry Eye Syndrome; and Ocuvia, a front-to-back ocular treatment that includes ocudrip and ocugrid. It also provides Eye-D technology which treats glaucom... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 4
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BOLT
Full Company Profile

Financial Performance

Financial Statements